Skip to main content
. 2020 Aug 7;3(3):287–301. doi: 10.20517/cdr.2020.29

Figure 4.

Figure 4

Formation of the bottleneck and resistance by treatment. The treatment (i.e., TMZ in GBM) induces a population restriction (bottleneck) and elicits an evolution/adaptation to treatment through cellular reprogramming. TMZ: Temozolomide; GBM: Glioblastoma